NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) — Fred’s Team, MSK’s operating program, has made historical past by surpassing $100 million in whole funds raised for most cancers analysis. Since 1995, runners have joined Fred’s Team so as to add extra that means to their miles by elevating cash in assist of lifesaving research and scientific trials at MSK. This new milestone underscores the large dedication of each runner, donor, and supporter to constructing a greater future for folks with most cancers.
Over the years, the Fred’s Team group has geared up a whole lot of MSK most cancers consultants to make groundbreaking discoveries that proceed to rework what it means to be recognized with most cancers. In August 2022, the FDA permitted the primary focused remedy for sufferers with HER2-low breast most cancers, following findings from analysis led by MSK medical oncologist Shanu Modi, MD, whose work is funded by Fred’s Team. Fred’s Team additionally supported a latest MSK rectal most cancers scientific trial led by Andrea Cercek, MD, Section Head of Colorectal Cancer and Co-Director of the Center for Young Onset Colorectal and Gastrointestinal Cancers, and Luis Alberto Diaz, Jr., MD, Head of the Division of Solid Tumor Oncology and Grayer Family Chair. In a particularly uncommon prevalence, each affected person achieved full remission.
“The money raised by Fred’s Team provides our doctors and scientists with the resources they need to push boundaries in both research and care, making it possible for us to improve the lives of people with cancer, not just at MSK but around the world,” mentioned Lisa M. DeAngelis, MD, Physician-in-Chief, Chief Medical Officer, and Scott M. and Lisa G. Stuart Chair.
Fred’s Team runners select the realm of most cancers analysis they wish to assist. From day one, individuals have directed funding to advance progress for a lot of several types of most cancers, particularly pediatric cancers. Fred’s Team has allotted greater than $35 million to the Aubrey Fund for Pediatric Cancer Research, which celebrated its twenty fifth anniversary this 12 months. The Aubrey Fund stays an essential useful resource for researchers and clinicians tackling probably the most urgent challenges in pediatric most cancers.
“So many people’s lives have been touched by cancer. Fred’s Team gives you the opportunity to do something about it. I will never stop running,” mentioned Aubrey Barr, a longtime member of Fred’s Team and former affected person at MSK Kids, MSK’s pediatric most cancers program.
Fred’s Team was named after operating legend and co-founder of the New York City Marathon Fred Lebow, who underwent remedy for mind most cancers at MSK in 1991. Today, individuals worldwide placed on their orange Fred’s Team uniforms to honor family members and make a distinction that goes past the end line.
Official Fred’s Team occasions embody the TCS New York City Marathon, United Airlines NYC Half, TCS London Marathon, and BMW Berlin Marathon. Runners additionally tackle 5Ks, half-marathons, marathons, triathlons, and different races as a part of Fred’s Team’s Fundraise Your Way program.
MORE INFORMATION
About Fred’s Team
Fred’s Team is the operating program at Memorial Sloan Kettering Cancer Center (MSK). It offers each runner the chance so as to add extra that means to their miles by elevating cash for lifesaving most cancers analysis at MSK. Fred’s Team was named in honor of operating legend and co-founder of the New York City Marathon Fred Lebow, who underwent remedy for mind most cancers at MSK in 1991. 100% of the cash raised goes instantly into the labs at MSK, the place groundbreaking discoveries are making an actual distinction for folks world wide. Official occasions embody the TCS New York City Marathon, United Airlines NYC Half, TCS London Marathon, and BMW Berlin Marathon. For further info and to donate, go to www.fredsteam.org and observe Fred’s Team on Facebook, Twitter, and Instagram.
About Memorial Sloan Kettering Cancer Center
The folks of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular objective: to discover a treatment for most cancers. Our specialised care groups present customized, compassionate, knowledgeable care to sufferers of all ages. Informed by fundamental analysis executed at our Sloan Kettering Institute, scientists throughout MSK collaborate to conduct modern translational and scientific analysis that’s driving a revolution in our understanding of most cancers as a illness and bettering the power to stop, diagnose, and deal with it. MSK is devoted to coaching the subsequent era of scientists and clinicians, who go on to pursue our mission at MSK and across the globe. One of the world’s most revered complete facilities devoted solely to most cancers, we now have been acknowledged as one of many high two most cancers hospitals within the nation by U.S. News & World Report for greater than 30 years. For further info, go to www.mskcc.org.